Votrient 200 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FJE11
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,956
Award facts
- Contract value 100% obligated
- $22,955.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,955.92 to AmerisourceBergen Drug Corp for 120 tablets of Votrient 200 mg, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Votrient (pazopanib) is a targeted cancer therapy used in the treatment of advanced renal cell carcinoma and soft tissue sarcoma, representing a specialized pharmaceutical procurement supporting military and veteran healthcare requirements.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide. AmerisourceBergen's role as a prime pharmaceutical vendor reflects its significant capacity to meet federal medical supply demands across multiple therapeutic domains and geographic regions, supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJE11?
SPE2DB25FJE11 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FJE11 worth?
The government has obligated $22,956 on SPE2DB25FJE11.
Is contract SPE2DB25FJE11 an order under another contract?
Yes. SPE2DB25FJE11 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJE11 competed?
The extent of competition for SPE2DB25FJE11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award